Prevalence and impact of metabolic associated fatty liver disease in non-metastatic breast cancer women at initial diagnosis: a cross-sectional study in China.
Zhi-Yu JiangXin-Yu LiangLei HuLiang RanRui-Ling SheChen-Yu MaJun-Han FengJing-Yu SongZhao-Xing LiXiu-Quan QuBai-Qing PengKai-Nan WuLing-Quan KongPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Compared with health check-ups, BC patients have higher prevalence of HS/MAFLD. HS/MAFLD coexist with high prevalence of metabolic complications, and the risk of lymph node metastasis was significantly higher in BC women with HS than in BC women without HS.
Keyphrases
- lymph node metastasis
- risk factors
- metastatic breast cancer
- polycystic ovary syndrome
- end stage renal disease
- squamous cell carcinoma
- ejection fraction
- healthcare
- newly diagnosed
- public health
- mental health
- prognostic factors
- peritoneal dialysis
- papillary thyroid
- pregnant women
- metabolic syndrome
- risk assessment
- health information
- patient reported
- health promotion